The medicine Tuksya containing Tucitinib is used in treatment of patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting. The recommended dosage of Tuksya is 300 mg taken orally twice daily with or without food. Tuksya comes in 50 mg and 150 mg tablets to administer orally via the mouth.
One can readily buy Tukysa 50 mg in India from several certified generic medicine suppliers. To know more about Tuksya, dial us at 18008891064. https://www.indianpharmanetwork.in/tukysa-tucatinib/